Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of MBS303 in B-cell non-Hodgkin'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• MBS303

Snippet

Sponsor: Beijing Mabworks Biotech Co., Ltd. | Conditions: Non-Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: RECRUITING